Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.40 |
| ▸ | FDPS | P14324 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citronellic Acid SCHEMBL29715943 | 0.82 | ALOX15 (0.52) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| Citronellic Acid SCHEMBL29908535 | 0.82 | GGPS1 (0.52) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL6050718 | 0.73 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL991834 | 0.73 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| Citronellic Acid SCHEMBL28696560 | 0.72 | ALOX15 (0.50) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL29447139 | 0.71 | KDM4E (0.47) | ALOX15ALDH1A1 | |
| Acetic Acid SCHEMBL320127 | 0.71 | CA1 (0.40) | ALDH1A1TSHR | |
| SCHEMBL4810550 | 0.70 | ALOX15 (0.53) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL5136231 | 0.69 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSUSP2 | |
| SCHEMBL4608511 | 0.69 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220257767-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-08-18 | — | — | US | disclosed |
| EP-3946261-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | President And Fellows Of Harvard College (US) | 2022-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220257767-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | SLCO4C1, SLC47A1, ABCB11 | ALOX15 3128/4885ALDH1A1 898/4885GGPS1 4659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.